Advertisement

Topics

Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class

02:12 EST 1 Dec 2014 | BioPortfolio

This article has expired, however you can still download the PDF.
Preview:
With the diabetes market an important therapeutic area for a host of pharmaceutical manufacturers, this week's Physician Views poll will seek feedback from US-based endocrinologists on three key recent developments – discussion regarding pancreatic canc....

Other Sources for this Article

Original Article: Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class

NEXT ARTICLE

More From BioPortfolio on "Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...